Breeze-Courier | Taylorville, IL
weather sponsored by
Hickory Estates of Taylorville




Advanced Search
search sponsored by


LOGIN | SUBSCRIBE






home : columns : dr. k July 23, 2016

   
11/16/2012 10:15:00 AM
Dr. K for Nov. 16, 2012
Alzheimer's drugs target symptoms, not underlying causes

DEAR DOCTOR K: Can you tell me about medications to treat Alzheimer's disease? How do they work, and what do they do?

DEAR READER: The drugs currently available to treat Alzheimer's disease target the symptoms, but not the underlying causes of the disease. The memory loss, impaired thinking and personality changes seen in Alzheimer's disease come from a loss of neurons (nerve cells) and their connections with other neurons. The symptoms of Alzheimer's disease also come from a decline in levels of neurotransmitters -- brain chemicals that carry messages between nerve cells.

Currently, no treatment prevents or stops Alzheimer's. However, medications can improve symptoms in many patients, although only temporarily.

The FDA has approved five drugs for the treatment of Alzheimer's disease: donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne, formerly Reminyl), tacrine (Cognex) and memantine (Namenda). I've put a table of these medications, along with their side effects and some additional comments, on my website, AskDoctorK.com.

In some people, these drugs lead to modest improvements in memory and cognitive function (such as making decisions and exercising judgment).

Donepezil, rivastigmine, galantamine and tacrine belong to a class of drugs called cholinesterase inhibitors. They raise the levels of acetylcholine in the brain. (A deficiency in this neurotransmitter contributes to the memory problems of this disease.) The drugs are effective for people with mild to moderate Alzheimer's disease.

Memantine works differently. It blocks glutamate, another neurotransmitter. This is beneficial because too much glutamate can destroy neurons.

Other drugs are used to treat emotional and behavioral problems that often arise in people with Alzheimer's disease. These include antidepressants, anti-anxiety drugs and antipsychotics.

In addition to relieving depression, antidepressants often enhance the social functioning in a person with Alzheimer's disease. They may improve appetite and sleep and increase energy, too.

Anti-anxiety drugs may help a person with Alzheimer's disease who is anxious, restless or agitated. Because they are also sedating, these medications often relieve insomnia and sundowning. (That's the worsening of behavior problems in the evening.)

Antipsychotic drugs may help manage behavior problems that result from delusions, hallucinations, paranoia, severe agitation and hostility.

Will there ever be treatments that can prevent Alzheimer's disease, or that can reverse the disease once it starts? I am cautiously optimistic. Over the past 25 years, enormous progress has been made in understanding what causes Alzheimer's disease, much of it from colleagues of mine here at Harvard Medical School.

Two molecules, called amyloid beta and tau, begin accumulating in the brain many decades before the symptoms begin. By measuring these molecules, doctors may be able to identify the people who are at risk for getting Alzheimer's disease decades before the symptoms start.

We now have treatments that reduce the levels of amyloid beta. They have not worked yet in humans who already have the disease. However, many experts think that the treatments may work better if started years before the symptoms of the disease appear in people at high risk. It will take a decade or more to know.

(Dr. Komaroff is a physician and professor at Harvard Medical School. To send questions, go to AskDoctorK.com, or write: Ask Doctor K, 10 Shattuck St., Second Floor, Boston, MA 02115.)


Anderson Jewelers




Article Comment Submission Form
Please feel free to submit your comments.

If you are looking for the SPEAK OUT submission form, you can find it by clicking here: Speak Out Form


Article comments are not posted immediately to the Web site. Each submission must be approved by the Web site editor, who may edit content for appropriateness. There may be a delay of 24-48 hours for any submission while the web site editor reviews and approves it.

NOTE: All information on this form is required. Your telephone number and email address will not be displayed or shared.
Submit an Article Comment
First Name:
Required
Last Name:
Required
Telephone:
Required
Email:
Required
Comment:
Required
Passcode:
Required
Anti-SPAM Passcode Click here to see a new mix of characters.
This is an anti-SPAM device. It is not case sensitive.
   












Trinity Dodge Fixed

NewsWebPagesOpinionPeopleObituariesAg & BusinessSportsContact Us
Subscriptions | Username & Password Reminder | Change Password | Life

Breeze-Courier & Printing | 212 S Main St. Taylorville, IL 62568 | (217) 824-2233 |
website@breezecourier.com

© Copyright 2014 Breeze-Courier & Printing. All Rights Reserved.
Original content may not be reprinted or distributed without the written permission of Breeze-Courier & Printing.

Software © 1998-2016 1up! Software, All Rights Reserved